CARIBOU BIOSCIENCES INC shareholders Q3 2022

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 115 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.4%.

CARIBOU BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 544,196$5,741,00019.52%
Elmwood Wealth Management, Inc. 2,364,240$24,943,00012.45%
72 Investment Holdings, LLC 474,067$5,001,0003.96%
PFM Health Sciences, LP 6,000,000$63,300,0002.29%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 257,892$2,716,0000.87%
Avidity Partners Management LP 3,172,600$33,471,0000.68%
Green Alpha Advisors, LLC 69,376$732,0000.62%
Rokos Capital Management LLP 1,907,509$20,811,0000.62%
Nelson Capital Management, LLC 85,020$897,0000.26%
Tekla Capital Management LLC 567,147$5,983,0000.24%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 90,652$956,0000.19%
Duquesne Family Office 271,430$2,864,0000.16%
MAVERICK CAPITAL LTD 652,542$6,884,0000.16%
STANSBERRY ASSET MANAGEMENT, LLC 67,662$714,0000.15%
KETTLE HILL CAPITAL MANAGEMENT, LLC 37,200$392,0000.09%
SHELTON CAPITAL MANAGEMENT 172,800$1,823,0000.09%
Virtus ETF Advisers LLC 20,369$215,0000.09%
Granahan Investment Management 238,204$2,513,0000.08%
Long Focus Capital Management, LLC 65,000$686,0000.07%
FARALLON CAPITAL MANAGEMENT LLC 896,369$9,457,0000.05%

This page lists CARIBOU BIOSCIENCES INC's shareholders in Q3 2022. To view CARIBOU BIOSCIENCES INC's shareholder history, click here.